+ All Categories
Home > Documents > Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur...

Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur...

Date post: 06-Mar-2018
Category:
Upload: lytuong
View: 300 times
Download: 33 times
Share this document with a friend
29
Leitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B. V., Leeuwerik 2, NL-3191 DL Hoogvliet 2005
Transcript
Page 1: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

Leitfaden zur

Horvi-Enzym-Therapie

Information to the

Horvi-enzyme therapy

Horvi-EnzyMed Holland B. V., Leeuwerik 2, NL-3191 DL Hoogvliet

2005

Page 2: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

He who heals is rightParacelsus, Philipp Aureolus Theophrast Bombast von Hohenheim

Doctor – Nature researcher – Philosopher – Pioneer of modern medicineBorn 1493 in Einsiedeln – died 1541 in Salzburg

The word Paracelsus, which today still retains its validity even morethan ever, deserves pride of place in these guidelines on the Horvi-enzyme therapy. This therapy was developed and researched over 65years ago by the pharmacist and chemist Dr. Waldemar Diesing. Dr.Diesing was a pupil of the German physiologist and 1931 winner of theNobel Prize for Medicine, Otto Warburg, the discoverer of the essentialenzyme Cytochrom-c-oxidase, which Otto Warburg called “respiratoryfermentation”, and whose structure was only clarified a few years agoby a group of Japanese researchers.

Dr. Diesing (previously of Horvi-Chemie) then founded his “Institute forexperimental animal research”, where he succeeded for the first time inproducing de-proteinised pure animal toxins from the raw venom ofsnakes, spiders, scorpions and salamanders. At the same time, hediscovered in each of these pure toxins the characteristics enzymescontained in them, which occur in them in many different natural forms.Each of these pure toxins which he researched and developed formedical treatment purposes contains between 35 to 50 enzyme types,whose natural composition must not be changed, since they will thenlose part of their effectiveness, and can then even cause many sideeffects. Dr. Diesing succeeded in developing a manufacturing processthat took this into account, so that the enzyme types in the individualpure toxins underwent no changes. He also succeeded in almost com-pletely removing the protein bonds, reducing them from the original85% to 1.8-2%, without damaging the enzymes.

ENZYMES (Ferments – Greek “en zyme” = in yeast) are proteins thatare essential for the metabolic processes of all organism (including thehuman organism), and which as biological catalysts* assist biochemicalprocesses by reducing or accelerating the necessary activation energy,and enable the process to take place in the required way, without them-selves undergoing any chemical change.

Through their protein structure, they are able to identify the materialwhose reaction they are intended to control (substrate specificity), the-reby enabling a wide range of simultaneous metabolic processes. Thisprotein bio-synthesis of enzymes differs depending on the organ and onthe individual enzyme in question (enzyme polymorphism).

1

Page 3: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

(*Catalysis is the process of accelerating a reaction, without whichthese organic reactions would be impossible.)

A disease beaks out due to an enzyme defect, which means an enzy-me blockage of a metabolic process. This enzyme inhibition can occurdue to an acquired inactivity or the hereditary, genetic lack of a particu-lar enzyme. If the correct enzyme is now supplied by means of Horvi-enzyme therapy, this usually brings about a cure, especially in the caseof an acquired inactivity of the enzyme inhibition. From this comes thestatement by Dr. Diesing: The Horvi-enzyme preparations do not com-bat any symptoms, although they are still genuine curative agents – afact which has been confirmed over the last 65 years by innumerablepatients in human and animal medicine.

To all critics and sceptics, let it be said here: in the healing of animals,the reference to a placebo effect can certainly not apply! AESCULA-PIUS, the son of Apollo, the Greek god of healing, carried with him thestaff of Aesculapius as early as 293 BC. The staff of Aesculapius wasembellished with coiled snakes, symbolising the status of a healer, theart of medicine and medical knowledge. The staff of Aesculapius canstill be found represented today on the letterheads of many therapists,so that this medical symbol of the snake is still in current use and notyet been forgotten.

The firm of Horvi-EnzyMed Holland B.V. is now continuing the life’swork of Dr. Waldemar Diesing, and offering its benefits for the goodof both humans and animals. A form of medicine based on over 65years of EXPERIENCE, and which has therefore been successfullytested and is free of side effects even in the case of long-termtreatment.You are requested however to observe the following instructionsclosely, since Horvi-EnzyMed Holland B. V. cannot accept anyliability for improper use of the preparations.

Points to note in Horvi-enzyme therapy:Administration of liquids:

If several Horvi-liquids are being taken, these should not be taken as amixture. Always allow approx. 5 to 10 minutes between taking differentliquids.

When taking several liquids, these should always be taken separately.For example, if 4 different liquids are being taken, 2 should be takenbefore a meal and 2 some time after a meal.2

Page 4: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

Keep all drops in the mouth for at least 1 minute, so that they are almostcompletely absorbed through the mucous membranes of the mouth!

In case of very sensitive mucous membranes, the drops can also betaken with 1/2-tsp. of water. This mixture should then be kept in themouth for at least 3 minutes. (All Horvi-liquids contain 20% alcoholas a preservative; 15 drops therefore contain the same amount ofalcohol as 1/2-tsp. of beer.)If the Horvi-liquids are mixed, this will change the method of action!They must also not be mixed with any homeopathic medicines!

Administration of injections:Horvi-enzyme injections should never be administered at the same timeas taking injections of other manufacturers whose instructions statethat occasional allergic reactions may occur! Never mix with ampoulessupplied by other manufacturers!

Horvi-enzyme preparations must not be used for patients with ahighly allergic reaction to animal proteins (extremely rare), sincethe preparations still contain 1.8 to 2% animal protein.Do not mix Horvi ampoules, since this will not only change the methodof action, but also increase the risk of allergies!

The individual ampoules that can be mixed are Horvi-enzyme Crotalusmite or forte with 1 ampoule Horvi-Curare 4 or Horvi-Curare 5!

Curare 4 is usually sufficient when mixed with Crotalus mite or forte asa catalyst. Curare 5 is generally added in cases of severe spasticity,palsy, severe dyspnoea and “grand mal” epilepsy.

Contraindications for Curare 4 and Curare 5 are: myasthenia, myas-thenia gravis, all diseases in which bulbar paralysis can occur as asymptom of the disease, such as amyotrophic lateral sclerosis (ALS),schizophrenia, psychoses and localised brain psycho-syndrome,medulla tumours, etc.

25 mg of Vitamin B 1 can also be mixed with the following ampoulesas a catalyst:

Horvi-enzyme Horvitrigon mite / forte – Horvi-enzyme Crotalus mite / forte –Horvi-enzyme Ammodytes mite / forte – Horvi-enzyme Bitis mite / forte

The Horvi-enzyme Horvitrigon mite / forte can also be mixed with up to 1 ml of the patient’s own blood, which is particularly advisablein the case of allergic diseases and immune deficiencies. If thepatient’s own blood is added, Vitamin B 1 should not be added tothe mixture.

3

Page 5: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

Two different Horvi-enzyme ampoules can be injected at the same time,though this should be done separately, i.e. intra-muscular or deep sub-cutaneous. Do not create any blisters, since this can cause local reac-tions. Never inject the ampoules into the oral or genital areas!

In rare cases, local reactions can occur at the point of injection;these are not allergic reactions! Local reactions manifest themselves inthe form of inflammation or swelling, and the area can also becomesomewhat hot. This can be treated by rubbing in Horvi-Serpalgincream. Do not administer injections to areas of local reaction until thereaction has subsided again. These local reactions can be avoided bymassaging the area thoroughly following every injection, so that thepreparation is spread throughout the tissue as quickly as possible oradding 1 ml NaCI (= salt solution) to the ampoules. These local reac-tions have no therapeutic disadvantage, on the contrary, they can evenhave very positive effects in the case of some diseases such as rheu-matism, and will then completely disappear after 2 to 3 weeks of Horvi-enzyme therapy.

All Horvi-enzyme ampoules can also be administered orally as drinkingampoules. The ampoule contents are placed on the tongue, andshould then be kept in the mouth for at least 3 minutes. This form ofapplication is particularly suitable for small children, since they containno alcohol. In the case of small children, the ampoule contents aredrawn up into a syringe, and the mother administers the ampoule con-tents to the child (without a hypodermic needle of course) in 2 to 3doses throughout the day, undiluted in the mouth. Children under 2years old should be given the ampoule contents by the mother in dropform throughout the day. The ampoule contents should always be keptsterile throughout the day, until the next application, in the syringe.

Do not use any drinking ampoules for the treatment of life-threate-ning diseases – this could be extremely dangerous! If a cancerpatient does not want any injections, please refrain from Horvi the-rapy; the patient should then preferably use other forms of treat-ment.

4

Page 6: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

Information on medications that should notbe used in conjunction with Horvi-enzyme

therapy:If cancer patients are receiving so-called immune modulators such as:monoclonal antibodies from mice (Herceptin) or monoclonalmouse/human antibodies (Mabthera), Interferon, Interleucine,Baypamun, Ukrain, ATC, mistletoe, Thymus, please refrain from Horvi-enzyme therapy!

If patients are undergoing chemotherapy, which runs in 2 – 3 weekcycles, Horvi-enzyme therapy can (should!) be administered in thetreatment intervals between the chemotherapy; Horvi-enzyme injec-tions should not be administered on the same days as chemotherapy.

If chemotherapy is being administered weekly, the treatment intervalsbetween the chemotherapy cycles are in this case too short to allow theHorvi-enzyme therapy to work effectively. (This is more akin to a battlebetween David and Goliath, in which Goliath always emerges the vic-tor.) In such cases it would not be an outright mistake to weigh up thepossible benefits and adverse effects, in case of such frequently pallia-tive chemotherapy treatment, since the patient must not be forgottencompletely, despite everything feasible! (As such a patient once said:“These frequent chemotherapy treatments have certainly not extendedmy life, it just seemed longer because of all the suffering caused by thechemotherapy!)

Horvi-enzyme therapy can (should!) be administered in parallel withradiation treatment!

In the case of multiple sclerosis patients who are receiving (Betaferone=) Betaferon, Avonex, Rebif or cytostatics, such as Methotrexat (MTX),Novantron etc., please refrain from Horvi-enzyme therapy!

In the case of rheumatism patients receiving immune-suppressants andmalaria treatments, MTX, please refrain from Horvi-enzyme therapy!

If immune-suppressants are being used to treat collagenoses (auto-immune diseases), please refrain from Horvi-enzyme therapy! Neveruse immune-stimulating medications in cases of collagenosis!Horvi-enzyme therapy is contraindicated for all patients with organtransplants; such patients must always take immune-suppressantsto combat organ rejection reactions. Therefore please refrain fromHorvi-enzyme therapy!For patients taking medications which affect blood coagulation (suchpatients should always have their prothrombin time checked), who are

5

Page 7: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

then given anticoagulant therapy with Marcumar, do not administerHorvi injections, since this could lower the prothrombin time. Oral medi-cation with the liquid preparations is however still possible.

For patients receiving the bacterial toxin “Clostridium botulinum” =Botox (for blepharospasm and spasmodic torticollis), please refrainfrom Horvi-enzyme therapy! Even after discontinuation of Botox, Horvi-enzyme therapy makes little sense, since the iatrogenic damage cau-sed by Botox can be irreversible, and Horvi-enzyme therapy will no lon-ger be effective.

Cortisone is not contraindicated in conjunction with Horvi-enzyme the-rapy, and can if necessary be administered in parallel with Horvi-enzy-me therapy. However: Cortisone should wherever possible only be usedas a temporary measure, and not a permanent treatment method, sincelong-term treatment with Cortisone also causes irreversible damage.Cortisone should however never be discontinued abruptly, but shouldgradually be reduced and finally discontinued after several weeks ofHorvi therapy. In the case of patients with an adrenocortical deficiency(Addison’s disease, anterior hypophysis lobe deficiency etc.), Cortisoneis essential, and cannot be discontinued in such cases!

Internal company details:The new company address is:

Horvi-EnzyMed Holland B.V.Leeuwerik 2

3191 DL HoogvlietNetherlands

Requests for Horvi-EnzyMed documentation and acceptance oforders can only be carried out through the German office:

Tel.-No.: 06835-50040Fax-No.: 06835-500444

E-mail address: [email protected]: www.horvi-enzymed.com

Our telephone times are as follows: Mon. – Fri. from 08:00 – 12:00

Horvi-EnzyMed preparations are supplied only by:Horvi-EnzyMed Holland B.V.

Since the preparations are manufactured and delivered by a Dutchcompany, we regret that no sample deliveries can be made, since thisis not the normal practice in the Netherlands, and there are thereforealso no applicable legal regulations.6

Page 8: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

Due to the removal of the manufacturing location and company headoffice, the product names have also been changed slightly: Thechange in the product names is shown by the following examples,which apply for almost all preparations:

Old: Horvi-C 33 Pure Toxin - New: Horvi-enzyme C 33Old: Horvi Ammodytes Pure Toxin - New: Horvi-enzyme Ammodytes miteOld: Horvi Ammodytes- Pure Toxin forte - New: Horvi-enzyme Ammo-dytes forte

Specialist presentations on Horvi-enzyme therapy will in future onlybe possible by arrangement with Mrs. Zenner, who can be contactedthrough the German office.

Horvi documentation, compendium etc. can only be requested inwriting, together with the practice stamp or non-medical practitionerregistration certificate.

Written request by doctors with the practice stamp and doctor’s sig-nature.

Written request by chemists with letterhead and chemist’s signature.

Individual therapy suggestions can be requested from thegerman office; requests must be accompanied by examination fin-dings, with current and relevant laboratory parameters and a descrip-tion of the complete medication prescribed. (Partial copies of findingsand information on pathological laboratory parameters only is not suffi-cient!)

In the case of more straightforward illnesses, a medical history shouldat least be compiled, pointing out the current symptoms and describingthe complete medication prescribed.

In anticipation of further successful co-operation in the future, weremain,

Horvi-EnzyMed Holland B.V.

Werner und Marion Zenner

General terms and conditions of businessDelivery and dispatch methods:

Orders can only be accepted by:Telephone: 06835-500 40

Fax: 06835-500 444E-mail: [email protected]: www.horvi-enzymed.com

7

Page 9: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

A 2% discount on the net goods value can also be granted to regi-stered customers.In case of orders placed through our Internet shop, you will automati-cally receive following the order a registration with customer No. andpassword. For all subsequent Internet shop orders placed using yourcustomer No. and password, you will receive a 2% discount on thenet goods value. For orders placed without the customer No. andpassword, the 2% discount cannot be applied.

Deliveries to therapists and chemists: Against invoice + € 7.00carriage, orders above € 250.00 carriage-paid within Germany andHolland.

Deliveries to private customers: Advance payment + € 7.00 carriage,orders above € 250.00 carriage-paid within Germany and Holland.Orders below a net value of € 150.00 will be subject to a minimumquantity surcharge of € 10.00.

Deliveries outside Holland and Germany Advance payment only, plusfreight costs.

Delivery of an ampoule test set – Contents 26 ampoules each 1 ml –Price € 30.00 + freight costs (special net prices not subject to settle-ment discount or discount)

Order forms and price lists can be requested by fax. Fax call-off No.: 06835-500456 or via the Internet: www.horvi-enzymed.com Deliveries of Horvi preparations can be made only to the invoicee.

Horvi preparations ordered and properly delivered cannot bereturned!

The goods delivered remain the property of Horvi-EnzyMedHolland B. V. until full payment has been received. For all deliveries,the invoice also applies as the order confirmation.

Place of jurisdiction: NL Rotterdam – Delivery and payment condi-tions apply as agreed here.

Alphabetical list of preparationswith major indications

The preparations are available in the following packagingsizes:1 ml AMPOULES of 10, 30, 50, 100 ampoules.

8

Page 10: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

DROPS containing 30 ml, 50 ml, 100 mlSALVES 100 ml (50 ml tubes only available as long as stocks last.)Horvi-Orocid Tablets: Contents 100 tabletsHorvi-Haarlem Oil Capsules: Contents 90 capsulesHorviton Tablets: Contents 100 tabletsHorvibidon Tablets: Contents 100 tablets (available from 2005)Horvi Hair Tonic (available from 2005)

HORVI-ENZYME AB 3 – DROPSBronchial asthma, bronchial emphysema, congestive bronchitis withleft heart deficiency, pollenosis with bronchial involvement

HORVI-ENZYME AMMODYTES (forte) – DROPS – AMPOULES –SALVENeuralgias of all types, rheumatic diseases, arthrosis deformans,osteoarthropathy, arthritis, polyarthritis, ostitis, osteomyelitis,osteoporosis, Bechterew’s disease (= spondylitis ankylosans)

HORVI-ANTIRHEUMATICUM – LIQUIDAll rheumatic und similar diseases such as muscular rheumatism, jointrheumatism, arthritis urica, and as a pain-relieving addition to spondy-losis therapy

HORVI-ENZYME AP 7 – DROPSAngina pectoris, myocardial infarction, glycoside heart deficiency, asgood cardiac support in cases of pneumonia, muscular heartdeficiency and high blood pressure in cases of apoplexy, and for thefollow-up treatment of apoplexy

HORVI-ENZYME BITIS (forte) – DROPS – AMPOULES – SALVEChorea, neurasthenia, hysteria, thrombosis, varicose symptom com-plex, multiple sclerosis, Parkinson’s syndrome, palsy symptoms, spa-sticity

HORVI-ENZYME BUFOMARIN (forte) – DROPSGeneral circulatory deficiencies, hypotonic symptom complex, heartcirculation deficiencies (Angina pectoris), heart weakness (especially inold age), myocarditis, pericarditis, endocarditis, pain relief of tumourpains, diabetes mellitus

HORVI-ENZYME BUTHUS – DROPS – AMPOULESParkinson’s syndrome, ataxia, asynergy, neurological mobility pro-blems, intention tremor, kinetosis, circulatory deficiencies, specially ofthe hypotonic type, polioencephalitis, bradyteleokinesis

HORVI-ENZYME C 33 – DROPS – AMPOULESSpecifically for cell tissue diseases with cell-activating symptom com-

9

Page 11: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

plex in benign and malignant tumour diseases, dysbacteria, all sto-mach-liver-pancreas-intestinal diseases, warts, geriatric complaints

HORVI-ENZYME C 300 – DROPS – AMPOULESFor extended effect in case of cell tissue diseases as described for C33, aphasia after apoplexy, retinal bleeding, amaurosis, gangrene, swel-ling of the lymph nodes, geriatric complaintsIMPORTANT NOTE: “C 33” and “C 300” are simply product names,and do not indicate the strength or concentration of the prepara-tion! Horvi-enzyme preparations are not homeopathic medicationsand therefore cannot be fractionated!HORVI-CARDOX – DROPSFor cardiovascular diseases, especially good for anginal ayspnoea,coronary sclerosis, coronary stenosis, improvement of oxygen utilisa-tion in the tissue, especially the heart muscle. For cyanosis in case ofpoor oxygen saturation of the blood. Hepatopathy of various types

HORVI-ENZYME CHIROPRAC SALVEChiropractic treatments, spondylosis deformans, spondylolisthesis,kinetosis, sciatic neuralgia, trigeminal neuralgia, joint chondromatosis,arthrosis deformans, myalgia rheumatica, neuralgia of various types,circulatory deficiencies. Helpful for bleeding, sprains, sports accidentsand over-exertion

HORVI-ENZYME CROTALUS (forte) – DROPS – AMPOULES –SALVEEpilepsy, chorea, neuralgia and neuropathy of all types, headaches,migraines, diseases of the central nervous system, depression, unrestand anxiety, bronchial asthma, bronchitis, coughing, sinusitis, pneumo-nia, autoimmune diseases, thyroid gland diseases, bleeding of all types,claudicatio intermittens, thromboses, Werlhof’s disease, liver-gallbladder-pancreas diseases, ostitis, arthritis, arthrosis, rhinitis vasomo-torica, feverHORVI-CURARE 4 – AMPOULESTetanus, epilepsy, multiple sclerosis, meningitis, paralysis agitans,hypertonia. Phlebitis, hysteria, dysmenorrhoea, bronchial asthma,eclampsia, peripheral circulatory deficiencies, neurological circulatorydeficiencies and mobility problems, spasticity – Curare 4 is used pri-marily by Crotalus (forte) as a catalyst (= reaction acceleration) and isadded to this preparation.

HORVI-CURARE 5 – DROPS – AMPOULES – the same indicationsapply here as for Curare 4. It is used in cases where a stronger relaxanteffect is required. It can also be added as a catalyst to Crotalus mite /forte.10

Page 12: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

CONTRAINDICATIONS IN THE USE OF CURARE 4 AND CURARE 5Psychoses – localised brain psycho-syndrome – schizophrenia –myasthenia – myasthenia gravis – and for all diseases in which bul-bar paralysis can occur, such as: amyotrophic lateral sclerosis(ALS), poliomyelitis, medulla tumours etc.

HORVI-ENZYME ELAPS (forte) – DROPS – AMPOULESLung tuberculosis with bleeding, lung embolism, stomach and intesti-nal bleeding, spastic processes of the digestive tract, menorrhagia,metrorrhagia, acute rhinitis, severe coughing, bronchial asthma, sinusi-tis, ozaena

HORVI-ENZYME EP 11 – DROPS – AMPOULESSpecifically for epilepsy (Petit mal and Grand mal), non-epileptic,psychomotoric excitement conditions, pycnolepsy, psychogenic crampattacks, endarteritis, trigeminal neuralgia

HORVICARD – LIQUIDVaso-motoric regulatory deficiencies of various types, inflammations ofthe heart muscle, symptoms of “Manager’s disease”, general heartproblems of old age, heart neuroses

HORVI-ENZYME HORVITRIGON (forte) – DROPS – AMPOULES –SALVESAllergies such as hay fever, eczema , agranulocytosis, all forms of dys-crasia malignant tumour diseases, epithelial tumours, thromboses,thrombophlebitis, myocarditis and endocarditis, septic conditions, cli-macteric complaints, apoplexy, gangrene, skin ulceration, haemorrha-gic diathesia, inflammations of various types, increasing the body’s owndefensive capabilities, geriatric complaints

HORVITYL – DROPSFor general nervousness and nerve weakness, sensitiveness to chan-ges in the weather, mood fluctuations, exam nerves, insomnia.Specifically for all symptoms accompanying the menopause, such asirregular menstruation, hot flushes, increased flow of blood to the head,heat sensations, depression, mood swings, irritability, hysteria, melan-cholia, balance deficiencies, anxiety psychoses, perspiration, skin irri-tation (particularly pruritus vulvae)

HORVIZYM SALVEVaso-motoric regulatory deficiencies of various types, heart weakness(old age), angina pectoris, general circulatory deficiencies, symptoms ofso-called “Manager’s disease”, support during the healing phase ofmyocarditis, pericarditis and endocarditis – warts

11

Page 13: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

HORVI-ENZYME LATROMACTAN – DROPS – AMPOULESChronic arthropathy of the knee and hip joints, spondylosis deformans,periarthropathia humeroscapularis, arachnoiditis ossificans, radiculitis,neuritis, precordial pain and anxiety, angina pectoris, bronchial asthma,dyspnoea, borrelioses, enteritis, gastroenteritis

HORVI-ENZYME MOKASSIN (forte) – DROPS – AMPOULESBleeding from unknown cause, specially with unchanged blood levels,nose-bleeds, uteral bleeding, Osler’s disease (polycythemia), purpurahaemorrhagica, purpura thrombocytopenika, for viral diseases such asherpes simplex, herpes zoster, malignant lymphatic diseases, psoriasisvulgaris

HORVI-ENZYME MS 9 DROPS – HORVI-ENZYME MS 9 I – AMPOULESHORVI-ENZYME MS 9 II – AMPOULESMultiple sclerosis, all inflammatory diseases of the central nervoussystem

HORVI-ENZYME NAJA mite and forte – DROPS

HORVI- ENZYME NAJA mite – AMPOULES – SALVESHeart pains, coronary deficiency, bronchial asthma, angina pectoris,embolisms as a result of heart problems, hypertonia, heart neuroses,dyspnoea, hyperthyroidism, collapse as a result of severe fluctuationsin blood pressure, eclampsia, sciatica, retinitis, optic nerve neuropathyand atrophy, glaucoma, cataracts, trigeminal neuralgia

HORVI-ENZYME PAT 9 – DROPSPolyarthritis, arthritis, joint neuroses, spondyloarthrosis, disc prolapse,intercostal neuralgia

HORVI-ENZYME PKS 6 – DROPSParkinson’s syndrome and hemi-parkinsonism, tremors of unknownorigin, restless-legs syndrome

HORVI-ENZYME PSY 4 – DROPSPsychic cramp syndrome, muscle relaxant, parkinsonism, hemiplegia,paraplegia, psychasthenia, angioneurosis, Raynaud’s syndrome

HORVI-ENZYME PSY 4 comp. 1 – DROPSPsychoneurotic problems, vegetative deficiencies of the circulatory andrespiratory system, temperamental disturbances, unrest, excitation,anxiety, depression

HORVI-ENZYME PSY 4 comp. 2 – DROPSHemiparesis, spasticity12

Page 14: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

HORVI-ENZYME PSY 4 comp. 3 – DROPSLaryngospasm, blepharospasm, facial cramps

HORVI-ENZYME PSY 4 comp. 4 – DROPSCardiovascular diseases affecting the heart and circulatory system,especially central nervous system disorders, paroxysmal tachycardia

HORVI-ENZYME PSY 4 comp. 5 – DROPSSevere depression and anxiety, obsessional neuroses, schizophrenia

HORVI-ENZYME RUSSELLI (forte) – DROPS – AMPOULESHaemostatics, haemorrhagia, haemophilia, thrombocytopenia,Werlhof’s disease, purpura, haemoglobinuria, nose-bleeds, and forheavy bleeding of all types

HORVI-ENZYME SERPALGIN – DROPS – AMPOULES – SALVESAll forms of neuralgia and neuropathy, pain conditions of all types, alsofor rheumatic diseases, cancer pains, hay fever, conjunctivitis, rhinitis,and for eye diseases, especially those affecting the optic nerve

HORVI-ENZYME TRITURUS – DROPS – AMPOULESEpilepsy, disturbances in temperamental and sexual behaviour, dys-arthria, hyperergia (hypersensitivity of the skin and tissue), nervousdisorders, ejaculatio praecox, hypertonis, acts as an analeptic , i.e. itexerts a stimulating effect on certain function centres in the central ner-vous system and relieves cramps

HORVI-ENZYME X 44 – DROPSAll cancers, especially epidermoid carcinoma, leucemia, malignantdiseases of the lymphatic system, lipoma, fibroma, adenoma, other skintumours

The following proven preparations are now beingproduced again in tablet and capsule form:

Horvi-Haarlem Oil Capsules (90 capsules) – dyspeptic complaintsdue to functional disorders of the liver, support of the bile flow and reliefof resulting symptoms such as: the feeling of satiety, tympania, obsti-pation, prevention of gallstones, spasms of the urinary tract, preventionof kidney stones. Contraindications: closure of the bile tract, gall-bladder empyema, cholangitis, cholecystitis, gallstones and kidneystones, jaundice, hyperbilirubinemia, hepatic disfunction, cirrhosis ofthe liver, liver cancer.

Horvibidon Tablets – Sexual debility in men following nervous disor-ders, stress due to mental or physical over-exertion, depression

Horviton- Capsules – physical and mental debility, vegetative dysto-nia, depression, neuroses, anxiety and panic feelings, insomnia, neuri-

13

Page 15: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

tides, restless-legs syndrome, stress – acts as a nerve tonic – causesno feeling of tiredness, so does not restrict driving ability of motorists.Depending on the severity of the mental condition, Horvi-enzyme PSY4 comp. 1 may be taken in addition.

Horvi-Orocid Tablets (100 Tabl.) – Fat metabolism disorders, fatty liverand liver diseases in general, reduces the toxicity of allopathic medica-tions on the liver, diabetes mellitus, intestinal disorders with tympania,obstipation or diarrhoea, dermatitis, muscle disorders

Horvi Hair Tonic – for external application only

Indications: Alopecia areata, diffuse hair loss

List of NUKLEOZYM COMPOUNDSPACKAGING SIZES: 30 ml – 50 ml – 100 mlSince the composition of Nukleozym has proven itself well in prac-tice, various compounds have been produced on this basis, whichafter many trials and tests have produced valuable special thera-peutics. These compounds have been given numbers, and shouldbe used in case of the following indications:HORVI-NUKLEOZYMSpecifically for cell-activating symptom complex of tumour diseases,and can therefore be used for all malignant diseases, as well as for: sto-mach-gall bladder-liver-pancreas-intestinal diseases of different types

HORVI-NUKLEOZYM comp. 1Special preparation for lung inflammation, lung defects in general

HORVI-NUKLEOZYM comp. 2Trigeminal neuralgia, migraines, headaches of all types

HORVI-NUKLEOZYM comp. 3Sciatica, spondyloarthrosis, arthritis, Bechterew’s disease, spastic spi-nal paralysis, tibialis palsy (palsy of the calf and foot musculature)

HORVI-NUKLEOZYM comp. 4Arthrosis deformans, polyarthritis, joint neurosis, muscular atrophy

HORVI-NUKLEOZYM comp. 5Rheumatism, especially rheumatism of the soft tissue, arteriosclerosis,hyperlipidemia

HORVI-NUKLEOZYM comp. 6Werlhof’s disease (ITP), thrombopenia

HORVI-NUKLEOZYM comp. 7Haemolytic anaemia, haemorrhoids, rectal prolapse14

Page 16: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

HORVI-NUKLEOZYM comp. 8Phlebitis, eczema, herpes zoster, trigeminal neuralgia, endangeitis obli-terans, thrombangeitis obliterans, psoriasis

HORVI-NUKLEOZYM comp. 9Thromboembolism, lung embolism, polycythemia rubra vera

HORVI-NUKLEOZYM comp. 11Hypertonia, tachycardia, hyperthyroidism, struma accompanied byheart muscle weakness

HORVI-NUKLEOZYM comp. 12Glaucoma, cataracts, conjunctivitis, uveitis, iridocyclitis, retinitis, poorvision

HORVI-NUKLEOZYM comp. 12 aGlaucoma with increased tendency to bleeding, poor vision, vitreousopacities, cataracts, uveitis, iridocyclitis, retinitis

HORVI-NUKLEOZYM comp. 13Liver cirrhosis with portal vein thrombosis, liver tumours, liver heman-gioma, nose-bleeds due to excess pressure caused by portal veinthrombosis and resulting headaches

HORVI-NUKLEOZYM comp. 14Lung cancer, lymphogranulomatosis (Morbus Hodgkin), non-Hodgkin’slymphoma

HORVI-NUKLEOZYM comp. 15Melanoma, basalioma

HORVI-NUKLEOZYM comp. 16Pelvic tumours with bleeding, brain tumour

HORVI-NUKLEOZYM comp. 17 Prostate cancer, prostate hyperplasia (prostate adenome), prostatitis

HORVI-NUKLEOZYM comp. 18Amyotrophic lateral sclerosis, dementia, Alzheimer’s disease

HORVI-NUKLEOZYM comp. 19Sclerodermia, CREST syndrome

HORVI-NUKLEOZYM comp. 20Apoplexy, ischemia syndrome, embolism, arterial circulation disorders

HORVI-NUKLEOZYM comp. 21Akrocyanosis (peripheral circulation disorders), Raynaud’s syndrome,cold agglutinin disease

HORVI-NUKLEOZYM comp. 25Lung tuberculosis, arthritis tuberculosa

15

Page 17: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

HORVI-NUKLEOZYM comp. 26Constipation, obstipation, megacolon, accretion and adhesion follo-wing operations in the abdominal area (prophylaxis)

16

Page 18: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

17

Haarlem Oil100 capsules containOleum lini sulf. 9.0 mlOleum therebinth. 9.0 mlOleum absynthi 0.36 mlOleum cajeput 3.24 mlOleum calami 0.13 mlOleum cinnamomi 0.13 mlOleum eucalypti 0.13 mlOleum foenicula 1.26 mlOleum juniperi 3.24 mlOleum majorani 0.63 mlOleum menth.pip. 0.31 mlOleum salvae 0.36 mlOleum spik 0.36 mlOleum thymi 0.63 mlOleum caryohyll 0.27 ml

Horvi-AntirheumaticsLiquidExtr. Summitates Pini 10.0 mlExtr. Turiones Pini 10.0 mlExtr. Flores e herbaGenistae scop. 3.0 mlExtr. Flores e herbaViolae tricol. 5.0 mlExtr. Flores Paeoniae 3.0 mlExtr. Flores Spiraea 3.0 mlExtr. Rhizoma Tormentillae 2.0 mlExtr. Strobuli Lupuli 2.0 mlExtr. Herba Hedera 3.0 mlExtr. Herba Lysmachia 2.0 mlExtr. Herba Polygoni avic. 2.0 mlExtr. Rutae graveolens 2.0 mlExtr. Ledi palustris 3.0 mlNicotine acid amide 0.07 gFormic acid 98 % 0.2 gLactic acid 90 % 0.03 gHexamethylentetramin 0.5 gLithium salicylate 0.5 gMagnesium salicylate 0.3 gRubidium bromide 0.01 gRubidium chloride 0.01 g

Sirup simplex 15.0 gContains 30 Vol.-% alcohol

HorvibidonComposition per tablet:Thlaminium dichloride 0.5 mgRiboflavin 0.2 mgNicotine acid amide 0.3 mgL (+)-Ascorbic acid 0.5 mgGlutamic acid 10.0 mgL-Leucin 10.0 mgDL-Valin 10.0 mgCalcium glycerol-phosphate 10.0 mgLecithin ex ovo 1.0 mgCitric acid 3.0 mgCaffeine pur. 0.5 mgNuces Cola 1.0 mgNuces Myristicae 0.5 mgExtr. Mulra Purama sicc. 10.0 mgGlandulae Testes pulv. sicc. 25.0 mgGlandulae Testiculum 15.0 mgWheatgerm flour 50.0 mgReduced milk powder 12.5 mg

HorvicardLiquidComposition per 100 mlExtr. fluidum Cacti grandiflor 2.0 mlExtr. fluidum Crataegi oxyacanth. 2.0 mlExtr. fluidum Sarothamni scopar 2.5 mlExtr. fluidum Leonuri cardiaca 1.0 mlExtr. fluidum Convallariae maj. 0.4 mlExtr. fluidum Primulae radix 0.4 mlExtr. fluidum Rutae graviol. 0.4 mlExtr. fluidum Spiraeaulmaria 0.4 mlExtr. fluidum Rosmarini 0.4 mlExtr. fluidum Chamomillae vulg. 0.2 mlExtr. fluidum Anserina potentilla 0.3 mlBufomarin 0.1 gAurum chloratum 0.01 gSirup simplex 25.0 mlContains 20 Vol.-% alcohol

Composition of preparations

Page 19: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

18

Horvi-CardoxLiquidElaps 0.5 µgNaja 0.5 µgBufotoxin 2.0 µgPangaminic acid 3.0 mgPotassium chloride 60 mgContains 20 Vol.-% alcohol

Horvi-Curare 4AmpoulesTubocurarin chloride 1.0 mlin isotonic sodium chloride solution

Horvi-Curare 5AmpoulesTubocurarin chloride 0.5 mgin isotonic sodium chloride solution

LiquidTubocurarin chloride 0.5 mgAuxiliary ingredients:Magnesium chloride 5.0 mgContains 20 Vol.-% alcohol

Horvi-enzyme AB 3LiquidNaja tripudians 0.25 µgElaps corallinus 0.25 µgBufotoxin of Bufo marinus 10.00 µgExtr. of Ammi visnagae fluidum 0.30 mlExtr. of Ephedra fluidum 0.10 mlExtr. of Thea fluidum 0.10 mlContains 20 Vol.-% alcohol

Horvi-enzyme Ammodytes(forte)Ampoules miteVipera Ammodytes 1.0 µgin isotonic sodium chloride solution

Ampoules forteVipera Ammodytes 2.0 µgin isotonic sodium chloride solution

Per 1 g salveVipera Ammodytes 0.3 µg

Cytochrom C 1.0 µgmyo-lnosit 1.0 mgNeutral salve base

Liquid miteVipera Ammodytes 0.5 µg

Liquid forteVipera Ammodytes 1.0 µgLiquids contain 20 Vol.-% alcohol

Horvi-enzyme AP 7LiquidNaja tripudians 0.25 µgNaja nivea 0.25 µgBufotoxin of Bufo marinus 2.0 µgCytochrom C 0.1 mgKhellin 3.0 mgContains 20 Vol.-% alcohol

Horvi-enzyme Bitis (forte)Ampoules miteBitis arietans 1.0 µgin isotonic sodium chloride solution

Ampoules forteBitis arietans 2.0 µgin isotonic sodium chloride solution

Per 1 g salveBitis arietans 0.3 µgCytochrom C 1.0 µgmyo-Inosit 1.0 mgNeutral salve base

Liquid mite

Bitis arietans 0.5 µg

Liquid forteBitis arietans 1.0 µgLiquids contain 20 Vol.-% alcohol

Horvi-enzyme Bufomarin (forte)Liquid miteBufo marinus 0.002 mgLiquid forteBufo marinus 0.005 mgLiquids contain 20 Vol.-% alcohol

Page 20: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

19

Horvi-enzyme ButhusAmpoulesButhus(Androctonus australis) 3.0 µgin isotonic sodium chloride solution

LiquidButhus(Androctonus australis) 1.0 µgLiquid contains 20 Vol.-% alcohol

Horvi-enzyme C 33AmpoulesLachesis muta 0.5 µgBothrops jararaca 0.5 µgThiamin hydrochloride 15.0 mgin isotonic magnesium chloride solution

LiquidLachesis muta 0.2 µgBothrops jararaca 0.2 µgNaja tripudians 0.1 µgBufo marinus 2.0 µgThiamin hydrochloride 5.0 mgCholine citrate 3.0 mgCitric acid 3.0 mgSuccinic acid 1.0 mgAmmonium chloride 5.0 mgAmmonium citrate 3.0 mgAmmonium copper chloride 3.0 mgCer-Ammonium sulphate 1.0 mgLiquid contains 20 Vol.-% alcohol

Horvi-enzyme C 300AmpoulesLachesis muta 0.5 µgBothrops jararaca 0.5 µgThiamin hydrochloride 15.0 mgHydroxypropiophenon 1.0 mgMagnesium chloride 10.0 mgin isotonic sodium chloride solution

LiquidLachesis muta 0.5 µgBothrops jararaca 0.5 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 15.0 mg

Hydroxypropiophenon 1.0 mgMagnesium chloride 10.0 mgContains 20 Vol.-% alcohol

Horvi-enzyme Chiroprac salveSalveComposition per 1 g salveVipera Lebetina 0.015 µgVipera Russelli 0.015 µgNaja tripudians 0.015 µgLatrodectus mactans 0.001 µgD (+) -Biotin 1.0 µgmyo-Inosit 1.0 mgCholine hydrogen-citrate 1.0 mgPyridoxin hydrochloride 0.05 mgProcaine hydrochloride 0.5 mgRiboflavin 0.3 mgAscorbic acid 1.0 mgExtr. of Milt aquosum 1:50 0.01 gExtr. of Thymus aquosum 1:10 0.1 gNeutral salve base

Horvi-enzyme Crotalus (forte)Ampoules miteCrotalus terrificus 1.0 µgin isotonic sodium chloride solution

Ampoules forteCrotalus terrificus 2.0 µgin isotonic sodium chloride solution

Liquid miteCrotalus terrificus 0.5 µg

Liquid forteCrotalus terrificus 0.1 µgLiquids contain 20 Vol.-% alcohol

Per 1 g salveCrotalus terrificus 0.3 µgCytochrom C 1.0 µgmyo-Inosit 1.0 mgNeutral salve base

Horvi rose of Sharon OilPer 100 ml Hypericin 4.0 mg– available from 2005 –

Page 21: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

20

Horvi-enzyme Elaps (forte)Ampoules miteElaps corallinus 1.0 µgin isotonic sodium chloride solutionAmpoules forteElaps corallinus 2.0 µgin isotonic sodium chloride solutionLiquid miteElaps corallinus 0.5 µgLiquid forteElaps corallinus 1.0 µgLiquids contain 20 Vol.-% alcohol

Horvi-enzyme EP 11AmpoulesBitis arietans 0.4 µgBitis gabonica 0.4 µgCrotalus terrificus 0.2 µgThiamin hydrochloride 5.0 mgHydantoin 5.0 mgin isotonic sodium chloride solution

LiquidBitis arietans 0.2 µgBitis gabonica 0.2 µgCrotalus terrificus 0.1 µgBufotoxin of Bufo marinus 3.0 µgThiamin hydrochloride 2.5 mgHydantoin 2.5 mgDextrose 3.0 mgLiquids contain 20 Vol.-% alcohol

Horvi-enzyme Horvitrigon (forte)Ampoules miteLachesis muta 1.0 µgin isotonic sodium chloride solution

Ampoules forteLachesis muta 2.0 µgin isotonic sodium chloride solution

Liquid miteLachesis muta 0.5 µg

Liquid forteLachesis muta 1.0 µgLiquids contain 20 Vol.-% alcoholPer 1 g salveLachesis muta 0.3 µgCytochrom C 1.0 µgmyo-Inosit 1.0 mgNeutral salve base

Horvi-enzyme LatromactanAmpoulesLatrodectus mactans 0.01 µgin isotonic sodium chloride solution

LiquidLatrodectus mactans 0.006 µgContains 20 Vol.-% alcohol

Horvi-enzyme Mokassin (forte)Ampoules miteAgkistrodon piscivoris 1.0 µgin isotonic sodium chloride solution

Ampoules forteAgkistrodon piscivoris 2.0 µgin isotonic sodium chloride solution

Liquid miteAgkistrodon piscivoris 0.5 µg

Liquid forteAgkistrodon piscivoris 1.0 µgLiquids contain 20 Vol.-% alcohol

Horvi-enzyme MS 9LiquidBitis arietans 0.25 µgCrotalus terrificus 0.25 µgThiamin hydrochloride 1.0 mgRiboflavin 0.1 mgNicotine acid amide 1.0 mgPyridoxin hydrochloride 0.25 mgAdenosin-triphosphate 0.25 mgContains 20 Vol.-% alcohol

Page 22: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

21

Horvi-enzyme MS 9 IAmpoulesBitis arietans 0.60 µgCrotalus terrificus 0.40 µgThiamin hydrochloride 5.0 mgPyridoxin hydrochloride 3.0 mgAscorbic acid 5.0 mgAdenosin-triphospate 3.0 mgin isotonic sodium chloride solution

Horvi-enzyme MS 9 IIAmpoules:Bitis arietans 0.60 µgCrotalus terrificus 0.40 µgNaja tripudians 0.45 µgThiamin hydrochloride 5.0 mgPyridoxin hydrochloride 1.0 mgAdenosin-triphospate 3.0 mgTubocuarin chloride 0.1 mlIn isotonic sodium chloride solution

Horvi-enzyme Naja (forte)Liquid miteNaja tripudians 0.5 µg

Liquid forteNaja tripudians 1.0 µgLiquids contain 20 Vol.-% alcohol

Per 1 g salveNaja tripudians 0.3 µgCytochrom C 1.0 µgmyo-Inosit 1.0 mgNeutral salve base

Horvi-enzyme PAT 9LiquidVipera Ammodytes 0.3 µgCrotalus terrificus 0.1 µgLachesis muta 0.1 µgTriturus cristatus 1.0 µgLatrodectus mactans 0.005 µgBufotoxin of Bufomarinus 2.0 µgFormic acid 80 % 20.0 mgAmmonium salicylate 20.0 mgAmmonium citrate 10.0 mgAmmonium chloride 5.0 mg

Ammonium phosphate 5.0 mgPotassium iodide 3.0 mgLithium citrate 3.0 mgMagnesium citrate 3.0 mgSodium gentisinate 1.0 mgContains 20 Vol.-% alcohol

Horvi-enzyme PKS 6LiquidBitis arietans 0.4 µgCrotalus terrificus 0.4 µgButhus australis 1.0 µgLatrodectus mactans 0.5 µgTriturus cristatus 0.5 µgDeoxyribonuclease90.000 D/E/mg 0.05 mgTubocurarin chloride(Curare D 4) 0.1 mlNicotine acid amide 1.0 mgAscorbic acid 1.0 mgProcain chloride 5.0 mgPyridoxin hydrochloride 0.03 gPotassium chloride 0.05 gContains 20 Vol.-% alcohol

Horvi-enzyme PSY 4LiquidBitis arietans 0.40 µgCrotalus terrificus 0.40 µgButhus australis 1.0 µgLatrodectus mactans 0.5 µgTriturus cristatus 0.5 µgDeoxyribonuclease90.000 D/E/mg 0.05 mgTubocurarin chloride 0.01 mgNicotine acid amide 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Page 23: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

22

Horvi-enzyme PSY 4 comp. 1LiquidBitis arietans 0.40 µgCrotalus terrificus 0.40 µgButhus australis 1.0 µgLatrodectus mactans 0.5 µgTriturus cristatus 0.5 µgDeoxyribonuclease90.000 D/E/mg 0.05 mgTubocurarin chloride 0.01 mgNicotine acid amide 1.0 mgAscorbic acid 1.0 mgThiamin hydrochloride 10.0 mgPyridoxin hydrochloride 5.0 mgContains 20 Vol.-% alcohol

Horvi-enzyme PSY 4 comp. 2LiquidDeoxyribonuclease90.000 D/E/mg 0.05 mgBitis arietans 0.40 µgCrotalus terrificus 0.40 µgButhus (Androctonus australis) 1.0 µgLatrodectus mactans 0.50 µgTriturus cristatus 0.50 µgCurare 0.01 mgNicotine acid amide 1.0 mgAscorbic acid 1.0 mgThiamin hydrochloride 10.0 mgPyridoxol hydrochloride 5.0 mgCyanocobalamin (Vit. B 12) 0.1 mgFolic acid 0.1 mgContains 20 Vol.-% alcohol

Horvi-enzyme PSY 4 comp. 3LiquidDeoxyribonuclease90.000 D/E/mg 0.05 mgBitis arietans 0.40 µgCrotalus terrificus 0.40 µgButhus (Androctonus australis) 1.0 µgLatrodectus mactans 0.50 µgTriturus cristatus 0.50 µgTubocuarin chloride 0.01 mgNicotine acid amide 1.0 mgAscorbic acid 1.0 mg

Elaps corallinus 1.0 µgPapaverin hydrochloride 0.01 mgContains 20 Vol.-% alcohol

Horvi-enzyme PSY 4 comp. 4LiquidBitis arietans 0.40 µgCrotalus terrificus 0.40 µgButhus australis 1.0 µgLatrodectus mactans 0.50 µgTriturus cristatus 0.50 µgElaps corallinus 1.0 µgDeoxyribonuclease 90.000 D/E/mg 0.05 mgTubocurarin chloride 0.01 mgNicotine acid amide 1.0 mgAscorbic acid 1.0 mgPangaminic acid sodium 20.0 mgContains 20 Vol.-% alcohol

Horvi-enzyme PSY 4 comp. 5LiquidBitis arietans 0.40 µgCrotalus terrificus 0.40 µgButhus australis 1.0 µgLatrodectus mactans 0.50 µgTriturus cristatus 0.50 µgDeoxyribonuclease 90.000 D/E/mg 0.05 mgTubocurarin chloride 0.01 mgNicotine acid amide 1.0 mgAscorbic acid 1.0 mgPapaverin hydrochloride 0.01 mgAjmalin 1.0 µgContains 20 Vol.-% alcohol

Horvi-enzyme Russelli (forte)Ampoules miteVipera Russelli 1.0 µgin isotonic sodium chloride solution

Ampoules forteVipera Russelli 2.0 µgin isotonic sodium chloride solution

Liquid miteVipera Russelli 0.5 µg

Page 24: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

23

Liquid forteVipera Russelli 1.0 µgLiquids contain 20 Vol.-% alcohol

Horvi-enzyme TriturusAmpoulesSamandarin 3.0 µgin isotonic sodium chloride solution

Liquid:Samandarin 1.0 µgContains 20 Vol.-% alcohol

Horvi-enzyme SerpalginAmpoules miteVipera Ammodytes 0.30 µgLachesis muta 0.35 µgNaja tripudians 0.35 µgin isotonic sodium chloride solution

Liquid miteVipera Ammodytes 0.10 µgLachesis muta 0.15 µgNaja tripudians 0.25 µgContains 20 Vol.-% alcohol

Per 1 g salveVipera Ammodytes 0.05 µgLachesis muta 0.10 µgNaja tripudians 0.15 µgmyo-Inosit 1.0 mgSorbite 5.0 mgNeutral salve base

Horvi-enzyme X 44LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgDeoxyribonuclease 0.1 mg90.000 D/E/mgHydroxypropiophenon 1.0 mgL-Asparaginase 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mg

Magnesium chloride 0.02 gContains 20 Vol.-% alcohol

Horvi-NukleozymLiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 0.1 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 1LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.2 µgDeoxyribonuclease 0.1 mg90.000 D/E/mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 2LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Page 25: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

24

Horvi-Nukleozym comp. 3LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgVipera Ammodytes 0.1 µgButhus australis 0.1 µgLatrodectus mactans 0.05 µgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 4LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Ammodytes 0.1 µgLatrodectus mactans 0.01 µgButhus australis 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 5LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Ammodytes 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgStrontium bromide 0.6 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 6LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Russelli 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 7LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Russelli 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgCobalt chloride 5.0 mgCobalt nitrate 5.0 mgIron citrate 5.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 8LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgBitis arietans 0.1 µgVipera Russelli 0.1 µg*Extr. Thuja occident 0.05 mgContains 20 Vol.-% alcohol

Page 26: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

25

Horvi-Nukleozym comp. 9LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgMagnesium citrate 2.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 11LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgTriturus cristatus 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 12LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgAgkistrodon piscivoris 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 12 aLiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µg

Vipera Russelli 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 0.1 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 13LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Russelli 0.1 µgTriturus cristatus 0.05 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 14LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgMagnesium chloride 2.0 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 15LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgBitis arietans 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Page 27: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

26

Horvi-Nukleozym comp. 16LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Russelli 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgAmygdalin puriss. 0.02 mgContains 20 Vo.-% alcohol

Horvi-Nukleozym comp. 17LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgLatrodectus mactans 0.05 µgTriturus cristatus 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgTubocurarin chloride 0.01 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 18LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Ammodytes 0.1 µgLatrodectus mactans 0.05 µgTubocuarin chloride 0.01 mgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgVitamin E 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 19LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgBitis arietans 0.1 µgLatrodectus mactans 0.05 µgTriturus cristatus 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 10.0 mgAdamantan puriss. 1.0 mgTubocuarin chloride 0.01 mgMagnesium chloride 2.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 20LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgVipera Russelli 0.1 µgBitis arietans 0.1 µgLatrodectus mactans 0.05 µgButhus australis 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 21LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgLatrodectus mactans 0.05 µgTriturus cristatus 0.1 µgTubocuarin chloride 0.05 mgDeoxyribonuclease90.000 D/E/mg 0.1 mg

Page 28: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

27

Thiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgPangaminic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 25LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgElaps corallinus 0.1 µgVipera Russelli 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgContains 20 Vol.-% alcohol

Horvi-Nukleozym comp. 26LiquidBothrops jararaca 0.1 µgLachesis muta 0.2 µgCrotalus terrificus 0.2 µgNaja tripudians 0.1 µgDeoxyribonuclease90.000 D/E/mg 0.1 mgThiamin hydrochloride 1.0 mgAscorbic acid 1.0 mgRiboflavin 0.1 mgNicotine acid amide 3 mgMethonin 1 mgCholine chloride 2 mgBetain hydrochloride 10 mgOrotic acid 10 mgContains 20 Vol.-% alcohol

HorvitonComposition per tablet:Aneurin (B1) 2.5 mgRiboflavin (B2) 0.75 mgPyridoxin (B6) 0.075 mgAscorbic acid 2.5 mgNicotine acid amide ( PP ) 2.5 mgCystine 0.75 mgLeucine 0.75 mg

Valine 0.075 mgGlutamic acid 7.5 mgCalc. glukonicum 5.0 mgCalc. glyc. phosph. 7.5 mgCalc. lacticum 1.25 mgFerrum sulf. 1.25 mgChlorophyllin 0.065 mgHaemoglobin 7.5 mgOrotic acid 1.25 mgEnterokinase 1.25 mgTestes 7.5 mgTesticulum 2.5 mgThymus 1.25 mgPapain 1.25 mgPapayotin 1.25 mgCorrigens: 108.15 mg

HorvitylLiquidLachesis muta 0.1 µgThiamin hydrochloride 1.0 mgRiboflavin 0.1 mgNicotine acid amide 5.0 mgß-Carotin 0.1 mgAscorbic acid 0.5 mgTocopherol succinate 0.1 mgPhenazone 3.0 mgAcetyl-choline chloride 5.0 mgExtr. of Shepherd’s Purse fluid. 0.1 mlExtr. of rose of Sharon fluid. 0.1 mlExtr. of Melissa fluid. 0.1 mlContains 40 Vol.-% alcohol

HorvizymSalveComposition per 1 g salveVipera Ammodytes 0.015 µgNaja tripudians 0.015 µgVipera Lebetina 0.0075 µgBufo marinus 0.1 µgLachesis muta 0.0075 µgCytochrom C 0.03 µgThiamin hydrochloride 0.03 mgNicotine acid amide 0.06 mgmyo-Inosit 0.03 mgAscorbic acid 0.03 mg

Page 29: Leitfaden zur Horvi-Enzym-Therapie Information to the ... · PDF fileLeitfaden zur Horvi-Enzym-Therapie Information to the Horvi-enzyme therapy Horvi-EnzyMed Holland B.V., Leeuwerik

p-Amino-benzoic acid 0.03 mgCalcium gluconicum 0.10 mgMagnesium citrate 0.10 mgDextroseWheatgerm oil 0.1 gExtr. of milt aquosum 1 : 10 0.03 gExtr. of Thymus aquosum 1 : 10 0.03 gNeutral salve base

Horvi-Orocid TabletsOrotic acid 0.1 gAneurin 0.004 gPP-factor 0.025 gCholine citrate 0.01 gInosit 0.01 gCytochrom C 0.001 mgDextrose 0.10 g

28


Recommended